Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ladarixin in New-onset Type 1 Diabetes
NCT02814838Phase 2Completed
- Sponsor
- Dompé
- Start
- Aug 2016
- Primary completion
- May 2019
- Modality
- Orthosteric Ligands
- Countries
- 3
01
Overview
Phase 2, randomised, double-blind trial of ladarixin in type 1 diabetes mellitus (T1D), sponsored by Dompé. Started Aug 2016; status: completed.
02
Drugs
ladarixin
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT02814838.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02814838.